Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Sales | 8,071 | 5,522 | 4,692 | 10,676 | 11,704 |
| Gross Profit | 8,071 | 5,522 | 4,692 | 10,676 | 11,704 |
| Operating Expenses | 14,841 | 11,034 | 9,998 | 14,648 | 33,026 |
| Operating Income | -6,770 | -5,512 | -5,306 | -3,972 | -21,323 |
| Interest Expense | 598 | 602 | 626 | 629 | 652 |
| Other Income | 737 | 101 | 195 | 258 | 388 |
| Pre-tax Income | -6,632 | -6,013 | -5,737 | -4,342 | -21,586 |
| Net Income Continuous | -6,632 | -6,013 | -5,737 | -4,342 | -21,586 |
| Net Income | $-6,632 | $-6,013 | $-5,737 | $-4,342 | $-21,586 |
| EPS Basic Total Ops | -72.07 | -69.07 | -57.06 | -60.06 | -294.29 |
| EPS Basic Continuous Ops | -70.98 | -69.43 | -59.54 | -59.02 | -293.49 |
| EPS Diluted Total Ops | -72.07 | -69.07 | -57.06 | -60.06 | -294.29 |
| EPS Diluted Continuous Ops | -70.98 | -69.43 | -59.54 | -59.02 | -293.49 |
| EBITDA(a) | $-6,570 | $-5,319 | $-5,134 | $-3,766 | $-21,091 |